[[(2R,3S,4R,5R)-5-[6-[benzyl(methyl)amino]-2-chloropurin-9-yl]-3,4-dihydroxytetrahydrofuran-2-yl]methoxyhydroxyphosphoryl]methylphosphonic acid

ID: ALA4452072

Chembl Id: CHEMBL4452072

PubChem CID: 146676950

Max Phase: Preclinical

Molecular Formula: C19H24ClN5O9P2

Molecular Weight: 563.83

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN(Cc1ccccc1)c1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)CP(=O)(O)O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C19H24ClN5O9P2/c1-24(7-11-5-3-2-4-6-11)16-13-17(23-19(20)22-16)25(9-21-13)18-15(27)14(26)12(34-18)8-33-36(31,32)10-35(28,29)30/h2-6,9,12,14-15,18,26-27H,7-8,10H2,1H3,(H,31,32)(H2,28,29,30)/t12-,14-,15-,18-/m1/s1

Standard InChI Key:  NRCRRUYZIFHEBT-SCFUHWHPSA-N

Alternative Forms

  1. Parent:

    ALA4452072

    ---

Associated Targets(Human)

NT5E Tchem 5'-nucleotidase (622 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Nt5e 5'-nucleotidase (305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 563.83Molecular Weight (Monoisotopic): 563.0738AlogP: 1.07#Rotatable Bonds: 9
Polar Surface Area: 200.59Molecular Species: ACIDHBA: 11HBD: 5
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 0.92CX Basic pKa: 2.14CX LogP: -1.08CX LogD: -4.55
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.18Np Likeness Score: 0.19

References

1. Bhattarai S, Pippel J, Scaletti E, Idris R, Freundlieb M, Rolshoven G, Renn C, Lee SY, Abdelrahman A, Zimmermann H, El-Tayeb A, Müller CE, Sträter N..  (2020)  2-Substituted α,β-Methylene-ADP Derivatives: Potent Competitive Ecto-5'-nucleotidase (CD73) Inhibitors with Variable Binding Modes.,  63  (6): [PMID:32045236] [10.1021/acs.jmedchem.9b01611]
2. Du X,Moore J,Blank BR,Eksterowicz J,Sutimantanapi D,Yuen N,Metzger T,Chan B,Huang T,Chen X,Chen Y,Duong F,Kong W,Chang JH,Sun J,Zavorotinskaya T,Ye Q,Junttila MR,Ndubaku C,Friedman LS,Fantin VR,Sun D.  (2020)  Orally Bioavailable Small-Molecule CD73 Inhibitor (OP-5244) Reverses Immunosuppression through Blockade of Adenosine Production.,  63  (18): [PMID:32865411] [10.1021/acs.jmedchem.0c01086]
3. Schmies CC,Rolshoven G,Idris RM,Losenkova K,Renn C,Schäkel L,Al-Hroub H,Wang Y,Garofano F,Schmidt-Wolf IGH,Zimmermann H,Yegutkin GG,Müller CE.  (2020)  Fluorescent Probes for Ecto-5'-nucleotidase (CD73).,  11  (11): [PMID:33214837] [10.1021/acsmedchemlett.0c00391]

Source